Is NIPT 100% accurate?

No, NIPT is a screening test, not a diagnostic test. It is over 99% accurate for trisomy 21 but can give false positives or false negatives. Positive results should be confirmed with CVS or amniocentesis.

Can NIPT give a false positive?

Yes, false positives can occur, especially for sex chromosome aneuploidies and microdeletions. The false-positive rate for trisomy 21 is less than 0.1%, but it is still possible.

How accurate is NIPT for gender?

NIPT is over 99% accurate for determining fetal sex when performed after 10 weeks, assuming sufficient fetal DNA is present.

What is the difference between NIPT and carrier screening?

NIPT screens for chromosomal conditions in the fetus (like Down syndrome). Carrier screening tests the parents for genetic mutations they could pass down, such as cystic fibrosis or spinal muscular atrophy. Both are often offered together.

Is NIPT 100% accurate?

No, NIPT is a screening test, not a diagnostic test. It is over 99% accurate for trisomy 21 but can give false positives or false negatives. Positive results should be confirmed with CVS or amniocentesis.

Can NIPT give a false positive?

Yes, false positives can occur, especially for sex chromosome aneuploidies and microdeletions. The false-positive rate for trisomy 21 is less than 0.1%, but it is still possible.

How accurate is NIPT for gender?

NIPT is over 99% accurate for determining fetal sex when performed after 10 weeks, assuming sufficient fetal DNA is present.

What is the difference between NIPT and carrier screening?

NIPT screens for chromosomal conditions in the fetus (like Down syndrome). Carrier screening tests the parents for genetic mutations they could pass down, such as cystic fibrosis or spinal muscular atrophy. Both are often offered together.

How Accurate Is Prenatal DNA Testing? A 2026 Guide for Expectant Parents

Discover how accurate NIPT and other prenatal DNA tests are in 2026. Learn about cell-free DNA, false positives, and when to confirm with diagnostic tests. US-focused guide.

Prenatal DNA testing, specifically non-invasive prenatal testing (NIPT) that analyzes cell-free DNA from a maternal blood sample, is highly accurate for detecting common chromosomal conditions such as trisomy 21 (Down syndrome), trisomy 18, and trisomy 13. In 2026, clinical studies consistently report a detection rate greater than 99% for these conditions, with a very low false-positive rate of less than 0.1%. However, accuracy varies by the specific condition screened, and NIPT is a screening test—not a diagnostic one—meaning positive results should be confirmed with diagnostic procedures like chorionic villus sampling (CVS) or amniocentesis.

Understanding the Technology Behind Prenatal DNA Testing

NIPT works by isolating the small fragments of fetal DNA that circulate in the mother’s bloodstream. This cell-free DNA is sequenced and analyzed for extra or missing chromosomes. The test is typically performed after 10 weeks of pregnancy and requires only a simple blood draw, posing no risk to the fetus.

What Conditions Can NIPT Screen For?

Common trisomies: Trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), and trisomy 13 (Patau syndrome) — detection rates >99% for trisomy 21, slightly lower for trisomies 18 and 13.
Sex chromosome aneuploidies: Conditions like Turner syndrome (45,X) and Klinefelter syndrome (47,XXY) — accuracy is lower, typically 90–95%.
Microdeletions: Small missing pieces of chromosomes, such as 22q11.2 deletion syndrome — accuracy ranges from 80% to 95% depending on the specific deletion.
Fetal sex: Very high accuracy (over 99%) for determining fetal sex from the presence of Y-chromosome DNA.

Factors That Influence Test Accuracy

Several factors can affect the reliability of NIPT results. Understanding these helps you interpret your screening results realistically.

Fetal Fraction

The proportion of cell-free DNA that comes from the placenta (fetal fraction) must be above a certain threshold—typically 4%—for accurate analysis. Low fetal fraction can occur in early gestation, with maternal obesity, or with certain medications, and may lead to a failed test or reduced accuracy.

Multiple Pregnancies

In twin or triplet pregnancies, NIPT is slightly less accurate because the test analyzes DNA from all fetuses together. Detection rates for trisomies in twins are still high (around 98% for trisomy 21), but false positives are more common.

Maternal Factors

Rare maternal chromosomal abnormalities (e.g., mosaicism, cancer) or a vanishing twin can interfere with results. A positive NIPT should always be followed by genetic counseling and confirmatory testing.

Accuracy Compared to Other Prenatal Screening Options

NIPT is the most accurate screening test available, but it is not the only one. The table below compares key screening methods used in the US.

Test Type	Detection Rate for Trisomy 21	False-Positive Rate	When Performed
NIPT (cell-free DNA)	>99%	<0.1%	10+ weeks
First-trimester screening (nuchal translucency + blood)	82–87%	~5%	11–13 weeks
Quad screen (second-trimester blood test)	75–80%	~5%	15–20 weeks
Integrated screening (first + second trimester)	94–96%	~5%	First + second trimester

Note: Diagnostic tests like chorionic villus sampling (CVS) and amniocentesis have near 100% accuracy for chromosomal abnormalities but carry a small risk of miscarriage (roughly 1 in 300 to 1 in 1,000 depending on the procedure and provider experience).

Screening vs. Diagnostic Testing: Why the Distinction Matters

NIPT is a screening test, meaning it estimates the risk that a condition is present. It is not definitive. A positive NIPT result indicates a higher likelihood, but only a diagnostic test (CVS or amniocentesis) can confirm the diagnosis. Conversely, a negative NIPT result is very reassuring but does not guarantee a perfectly healthy baby. Genetic counselors often recommend combining NIPT with carrier screening to assess the risk of inherited conditions like cystic fibrosis, spinal muscular atrophy, or fragile X syndrome.

What About Prenatal Paternity Testing?

Prenatal DNA testing can also determine paternity during pregnancy. Non-invasive prenatal paternity testing analyzes cell-free DNA from a maternal blood sample and compares it to a DNA sample from the alleged father. Accuracy exceeds 99.9% when performed after 8 weeks of gestation. This test is different from NIPT for medical conditions and is available separately.

How to Interpret Your Results

Your NIPT report will typically state “low risk” or “high risk” for each condition. A “high risk” result means the chance of the condition is elevated, but it is not a diagnosis. Always share results with your obstetrician or a genetic counselor, who can explain the positive predictive value (PPV) based on your age, the condition screened, and the test’s performance. For example, the PPV for trisomy 21 in a 25-year-old is lower than in a 40-year-old because the background risk differs.

If you receive a positive screen, your provider will likely offer diagnostic testing. CVS can be performed as early as 10–13 weeks, while amniocentesis is typically done after 15 weeks. Both provide definitive answers.

In summary, prenatal DNA testing (NIPT) is exceptionally accurate for the most common chromosomal conditions, but it is not perfect. Understanding its limitations helps you make informed decisions about next steps, including the option to pursue carrier screening or diagnostic follow-up.

If you’re ready to take the next step in your prenatal care journey, you can order a prenatal screening panel online and receive your results quickly, giving you peace of mind during your pregnancy.